About this trial
This is a clinical trial that includes a run-in period, a 90 day micro-randomized trial, and a 90-day observational period. The goal of this study is to evaluate whether providing paired real time glycemic and health behavior data in a smartphone app leads to better glycemic control among adolescents and young adults with T2D. Glycemic control will be monitored using Continuous Glucose Monitors (CGM), and health behavior data will be collected via a Fitbit activity tracker and a research app (Healthmine). Participants will be prompted to view and reflect on glycemic trends and health behavior data (Fitbit data, logging of diet and medication adherence) during the 90-day micro-randomized trial period, then observed for ongoing use of the Healthmine app and engagement with CGM in the following 90-day observation period.
Eligibility criteria
Qualifiers
type 2 diabetes: negative diabetes autoantibodies, no suspicion for monogenic diabetes
HbA1c ≥7.0%, stable medication use
HbA1c 6.0-6.9% without short-acting insulin, any other stable diabetes medication use
English-speaking (app in English)
Disqualifiers
Current pregnancy
Hydroxyurea use (CGM sensor inaccuracies)
Cognitive impairment or severe psychiatric condition that could interfere with participation in behavioral intervention for diabetes self-management
Current or previously diagnosed eating disorder
Trial design
Treatments tested in this trial
- Focused App Prompt
- No App Prompt
- Outreach for Missing Data
Treatment groups
Locations
1Sponsors and collaborators
University of Pittsburgh
Lead sponsor
Dartmouth College
Collaborator
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Collaborator
University of Michigan
Collaborator
San Diego State University
Collaborator
Emory University
Collaborator